Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-02-12

Clinical Trial Update: Role of Prophylactic Postoperative Antibiotics in HoLEP [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating prophylactic postoperative antibiotics after Holmium Laser Enucleation of the Prostate (HoLEP) has been withdrawn, sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Baylor Research Institute | Conditions: Benign Prostatic Hyperplasia, Urinary Tract Infections | Phase 4 | Status: WITHDRAWN